Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Phase 1 Study of PF-07265028 in Participants With Selected Advanced Solid Tumors
Category & Conditions: Cancer
Study Phase : 1
Medicine: PF-07265028
Language: English
ViewDownloadPrint
Study to Evaluate the Effect of Voxelotor in Participants 6 Months to 17 Years of Age With Sickle Cell Disease (HOPE-KIDS)
Category & Conditions: Rare Diseases
Study Phase : 2
Medicine: OXBRYTA(VOXELOTOR)
Language: English
ViewDownloadPrint
Study to Assess the Effect of Long-Term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 (034OLE)
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: OXBRYTA(VOXELOTOR)
Language: English
ViewDownloadPrint
Open-Label Extension Study of Voxelotor
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: OXBRYTA(VOXELOTOR)
Language: English
ViewDownloadPrint
Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease (HOPE Kids 2)
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: OXBRYTA(VOXELOTOR)
Language: English
ViewDownloadPrint
Resolution of Sickle Cell Leg Ulcers with Voxelotor (RESOLVE)
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: OXBRYTA(VOXELOTOR)
Language: English
ViewDownloadPrint
A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vasoocclusive Crises
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: INCLACUMAB(PF-07940370)
Language: English
ViewDownloadPrint
A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: INCLACUMAB(PF-07940370)
Language: English
ViewDownloadPrint
A Study to Learn About the Safety of Single and Multiple Doses of PF-07261271 in Healthy People
Category & Conditions: Gastrointestinal Disorders
Study Phase : 1
Medicine: PF-07261271
Language: English
ViewDownloadPrint
A Study of Maplirpacept in Combination With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer
Category & Conditions: Cancer
Study Phase : 1/2
Medicine: Maplirpacept
Language: English
ViewDownloadPrint
Effects of Maplirpacept (PF-07901801), Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Category & Conditions: Cancer
Study Phase : 1/2
Medicine: Maplirpacept
Language: English
ViewDownloadPrint
Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-advanced or Metastatic Triple-Negative Breast Cancer
Category & Conditions: Cancer
Study Phase : 1/2
Medicine: Ladiratuzumab Vedotin (LV; SGN-LIV1A)
Language: English
ViewDownloadPrint